Velpanat, Ulpanat

Velpanat, Ulpanat

"The combination of sofosbuvir and velvetelvis instructions for medical use."

The purpose of the drug: For treating chronic HCV chronic hepatitis C (any genotype).

Composition Velpanat: 400 mg sofosbuvir 100 mg valparasio in one tablet for daily oral administration.

The number of tablets in pack: 28.

Contraindications:

Simultaneous treatment of HIV (in the case of co-infection with HIV can consult the doctor, partitioning the treatment of hepatitis C and HIV in order);

Pregnancy and breastfeeding;

Aetiology and disease SS (taken with caution and under the supervision of a physician);

Forbidden simultaneous reception with lewsey, St. John's wort;

Minors the age of the patient;

Individual intolerance of the drug components.

Allergic reactions (in practice it is not revealed).